CASI CASI Pharmaceuticals, Inc Earnings per share growth rate in current year

CASI Pharmaceuticals is scaling the treatment of hematological pathologies through partnerships with global biolabs to expand in China. However, trade disputes between the US and China could limit the export of innovations. This linear chart of EPS year-over-year comparisons on GURU.Markets contains data where the current figure is 0.00. Stable management is successfully adapting the drug portfolio for government procurement.

CASI - CASI Pharmaceuticals, Inc Earnings growth in current year over the range 07/04/2022 - 03/14/2026

Analytical breakdowns and data insights for company casipharmaceuticals.com (CASI)

- stock value and consensus price forecast:

Market Price CASI Pharmaceuticals, Inc.|CASI - Price Target Chart

- market capitalization data:

Market Value CASI Pharmaceuticals, Inc|CASI - Enterprise Value

- balance sheet equity data:

Equity per Share CASI Pharmaceuticals|CASI - Book Capitalization|Market Cap to Net Assets Ratio casipharmaceuticals.com|CASI - Company Total Assets

- debt burden and liquidity indicators:

Total Debt to Capital CASI Pharmaceuticals|CASI - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient CASI Pharmaceuticals, Inc.|CASI - Company Aggregate Debts|Debts to Net Assets CASI Pharmaceuticals, Inc|CASI - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings CASI Pharmaceuticals|Critical Liquidity Ratio casipharmaceuticals.com

- earnings and market ratios statistics:

CASI - Net Profit|Expected Net Income CASI Pharmaceuticals|CASI - P/E Multiple|Forward P/E Multiple CASI Pharmaceuticals, Inc.|CASI - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation CASI Pharmaceuticals, Inc|CASI - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months CASI Pharmaceuticals|CASI - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth casipharmaceuticals.com|CASI - Earnings growth in current year|Expected earnings per share growth for next year CASI Pharmaceuticals

Fundamental valuation:CASI - CASI Pharmaceuticals, Inc

Manufactured product of CASI Pharmaceuticals, Inc

This indicator measures the dynamics of net earnings per share by calculating the percentage deviation of the current value from the same period last year. By analyzing the annual EPS growth rate on the GURU.Markets platform, an investor assesses the efficiency of capital generation. The metric identifies profitability trends stripped of market noise. For CASI Pharmaceuticals (CASI), this figure is critical due to pressure from new cell therapy methods. Stable EPS growth confirms the competitiveness of the company's patents in oncohematology.

Key competitors